{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:21:14Z","timestamp":1793319674571,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Central Plains Science and Technology Innovation Leading Talents","award":["204200510017"],"award-info":[{"award-number":["204200510017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11739-023-03481-8","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T09:14:42Z","timestamp":1702372482000},"page":"377-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-3998","authenticated-orcid":false,"given":"Yuansong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanye","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1826-5141","authenticated-orcid":false,"given":"Deliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"1","key":"3481_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-020-00862-w","volume":"13","author":"C Pan","year":"2020","unstructured":"Pan C, Liu H, Robins E, Song W, Liu D, Li Z, Zheng L (2020) Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy. J Hematol Oncol 13(1):29. https:\/\/doi.org\/10.1186\/s13045-020-00862-w","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3481_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","volume":"21","author":"AJ Korman","year":"2022","unstructured":"Korman AJ, Garrett-Thomson SC, Lonberg N (2022) The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nat Rev Drug Discov 21(7):509\u2013528. https:\/\/doi.org\/10.1038\/s41573-021-00345-8","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"3481_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, Shabafrouz K, Ribi C, Cairoli A, Guex-Crosier Y, Kuntzer T, Michielin O, Peters S, Coukos G, Spertini F, Thompson JA, Obeid M (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16(9):563\u2013580. https:\/\/doi.org\/10.1038\/s41571-019-0218-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"16","key":"3481_CR4","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","volume":"71","author":"SS Mahmood","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD, Neilan TG (2018) Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol 71(16):1755\u20131764. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.037","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"3481_CR5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA, Anders RA, Sosman JA, Moslehi JJ (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375(18):1749\u20131755","journal-title":"N Engl J Med"},{"issue":"10124","key":"3481_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","volume":"391","author":"JJ Moslehi","year":"2018","unstructured":"Moslehi JJ, Salem J-E, Sosman JA, Lebrun-Vignes B, Johnson DB (2018) Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet 391(10124):933. https:\/\/doi.org\/10.1016\/S0140-6736(18)30533-6","journal-title":"Lancet"},{"issue":"12","key":"3481_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"J-E Salem","year":"2018","unstructured":"Salem J-E, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano J-P, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ (2018) Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19(12):1579\u20131589. https:\/\/doi.org\/10.1016\/S1470-2045(18)30608-9","journal-title":"Lancet Oncol"},{"issue":"23","key":"3481_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018306","volume":"9","author":"ZD Drobni","year":"2020","unstructured":"Drobni ZD, Zafar A, Zubiri L, Zlotoff DA, Alvi RM, Lee C, Hartmann S, Gilman HK, Villani A-C, Nohria A, Groarke JD, Sullivan RJ, Reynolds KL, Zhang L, Neilan TG (2020) Decreased absolute lymphocyte count and increased neutrophil\/lymphocyte ratio with immune checkpoint inhibitor-associated myocarditis. J Am Heart Assoc 9(23):e018306. https:\/\/doi.org\/10.1161\/JAHA.120.018306","journal-title":"J Am Heart Assoc"},{"key":"3481_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107174","volume":"90","author":"A Abrishami","year":"2021","unstructured":"Abrishami A, Eslami V, Baharvand Z, Khalili N, Saghamanesh S, Zarei E, Sanei-Taheri M (2021) Epicardial adipose tissue, inflammatory biomarkers and COVID-19: is there a possible relationship? Int Immunopharmacol 90:107174. https:\/\/doi.org\/10.1016\/j.intimp.2020.107174","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3481_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","volume":"14","author":"AP Ambrosy","year":"2012","unstructured":"Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14(3):302\u2013311. https:\/\/doi.org\/10.1093\/eurjhf\/hfs007","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"3481_CR11","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.7150\/ijms.52405","volume":"18","author":"C Yao","year":"2021","unstructured":"Yao C, Wang L, Shi F, Chen R, Li B, Liu W, Feng M, Li S (2021) Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure. Int J Med Sci 18(7):1592\u20131599. https:\/\/doi.org\/10.7150\/ijms.52405","journal-title":"Int J Med Sci"},{"issue":"3","key":"3481_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaoncol.2017.4771","volume":"4","author":"L Mezquita","year":"2018","unstructured":"Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zer\u00f3n-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B (2018) Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol 4(3):351\u2013357. https:\/\/doi.org\/10.1001\/jamaoncol.2017.4771","journal-title":"JAMA Oncol"},{"issue":"2","key":"3481_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","volume":"140","author":"MP Bonaca","year":"2019","unstructured":"Bonaca MP, Olenchock BA, Salem J-E, Wiviott SD, Ederhy S, Cohen A, Stewart GC, Choueiri TK, Di Carli M, Allenbach Y, Kumbhani DJ, Heinzerling L, Amiri-Kordestani L, Lyon AR, Thavendiranathan P, Padera R, Lichtman A, Liu PP, Johnson DB, Moslehi J (2019) Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology. Circulation 140(2):80\u201391","journal-title":"Circulation"},{"issue":"13","key":"3481_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jama.2023.3371","volume":"329","author":"E Ammirati","year":"2023","unstructured":"Ammirati E, Moslehi JJ (2023) Diagnosis and treatment of acute myocarditis: a review. JAMA 329(13):1098\u20131113. https:\/\/doi.org\/10.1001\/jama.2023.3371","journal-title":"JAMA"},{"issue":"8","key":"3481_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.autrev.2017.05.021","volume":"16","author":"C Comarmond","year":"2017","unstructured":"Comarmond C, Cacoub P (2017) Myocarditis in auto-immune or auto-inflammatory diseases. Autoimmun Rev 16(8):811\u2013816. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.021","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3481_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"3481_CR17","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.117.029626","volume":"136","author":"G Varricchi","year":"2017","unstructured":"Varricchi G, Galdiero MR, Tocchetti CG (2017) Cardiac toxicity of immune checkpoint inhibitors: cardio-oncology meets immunology. Circulation 136(21):1989\u20131992. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029626","journal-title":"Circulation"},{"key":"3481_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-pharmtox-010919-023451","volume":"61","author":"S Waliany","year":"2021","unstructured":"Waliany S, Lee D, Witteles RM, Neal JW, Nguyen P, Davis MM, Salem J-E, Wu SM, Moslehi JJ, Zhu H (2021) Immune checkpoint inhibitor cardiotoxicity: understanding basic mechanisms and clinical characteristics and finding a cure. Annu Rev Pharmacol Toxicol 61:113\u2013134. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023451","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3481_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435","author":"JR Brahmer","year":"2021","unstructured":"Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB, Lacouture ME, Masters GA, Naidoo J, Nanni M, Perales M-A, Puzanov I, Santomasso BD, Shanbhag SP, Sharma R, Skondra D, Sosman JA, Turner M, Ernstoff MS (2021) Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002435","journal-title":"J Immunother Cancer"},{"issue":"8","key":"3481_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand J-B, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol 35(8):893\u2013911. https:\/\/doi.org\/10.1200\/JCO.2016.70.5400","journal-title":"J Clin Oncol"},{"issue":"8","key":"3481_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1634\/theoncologist.2018-0563","volume":"24","author":"A Pavan","year":"2019","unstructured":"Pavan A, Calvetti L, Dal Maso A, Attili I, Del Bianco P, Pasello G, Guarneri V, Aprile G, Conte P, Bonanno L (2019) Peripheral blood markers identify risk of immune-related toxicity in advanced non-small cell lung cancer treated with immune-checkpoint inhibitors. Oncologist 24(8):1128\u20131136. https:\/\/doi.org\/10.1634\/theoncologist.2018-0563","journal-title":"Oncologist"},{"issue":"1","key":"3481_CR22","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.1038\/s41598-021-88307-3","volume":"11","author":"D Michailidou","year":"2021","unstructured":"Michailidou D, Khaki AR, Morelli MP, Diamantopoulos L, Singh N, Grivas P (2021) Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors. Sci Rep 11(1):9029. https:\/\/doi.org\/10.1038\/s41598-021-88307-3","journal-title":"Sci Rep"},{"key":"3481_CR23","doi-asserted-by":"publisher","first-page":"22618","DOI":"10.1038\/srep22618","volume":"6","author":"H Zhang","year":"2016","unstructured":"Zhang H, Gao L, Zhang B, Zhang L, Wang C (2016) Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep 6:22618. https:\/\/doi.org\/10.1038\/srep22618","journal-title":"Sci Rep"},{"issue":"6","key":"3481_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00262-020-02793-4","volume":"70","author":"C Zamora","year":"2021","unstructured":"Zamora C, Riudavets M, Anguera G, Alserawan L, Sullivan I, Barba A, Serra J, Ortiz MA, Gallardo P, Perea L, Gavira J, Barnadas A, Majem M, Vidal S (2021) Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents. Cancer Immunol Immunother 70(6):1691\u20131704. https:\/\/doi.org\/10.1007\/s00262-020-02793-4","journal-title":"Cancer Immunol Immunother"},{"key":"3481_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0363-0","author":"SN Champion","year":"2020","unstructured":"Champion SN, Stone JR (2020) Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-019-0363-0","journal-title":"Mod Pathol"},{"issue":"11","key":"3481_CR26","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.5858\/arpa.2019-0447-OA","volume":"144","author":"I Sobol","year":"2020","unstructured":"Sobol I, Chen CL, Mahmood SS, Borczuk AC (2020) Histopathologic characterization of myocarditis associated with immune checkpoint inhibitor therapy. Arch Pathol Lab Med 144(11):1392\u20131396. https:\/\/doi.org\/10.5858\/arpa.2019-0447-OA","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"3481_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D, Waliany S, Huang YV, Ryan J, Dang K, Neal JW, Wakelee HA, Reddy SA, Srinivas S, Lin L-L, Witteles RM, Maecker HT, Davis MM, Nguyen PK, Wu SM (2022) Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation 146(4):316\u2013335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056730","journal-title":"Circulation"},{"key":"3481_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.914928","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Zheng X, Huang Q, Li X, Qiu M, Liu M (2022) Intrinsic differences in immune checkpoint inhibitor-induced myocarditis: a retrospective analysis of real world data. Front Pharmacol 13:914928. https:\/\/doi.org\/10.3389\/fphar.2022.914928","journal-title":"Front Pharmacol"},{"issue":"5","key":"3481_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jaccao.2022.11.004","volume":"4","author":"A Vasbinder","year":"2022","unstructured":"Vasbinder A, Chen Y, Procureur A, Gradone A, Azam TU, Perry D, Shadid H, Anderson E, Catalan T, Blakely P, Nelapudi N, Fardous M, Bretagne MC, Adie SK, Pogue KT, Leja M, Yentz S, Schneider B, Fecher LA, Lao CD, Salem J-E, Hayek SS (2022) Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor-induced myocarditis. JACC CardioOncol 4(5):689\u2013700. https:\/\/doi.org\/10.1016\/j.jaccao.2022.11.004","journal-title":"JACC CardioOncol"},{"issue":"3","key":"3481_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00392-022-02118-8","volume":"112","author":"B Waissengein","year":"2023","unstructured":"Waissengein B, Abu Ata B, Merimsky O, Shamai S, Wolf I, Arnold JH, Bar-On T, Banai S, Khoury S, Laufer-Perl M (2023) The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors. Clin Res Cardiol 112(3):409\u2013418. https:\/\/doi.org\/10.1007\/s00392-022-02118-8","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"3481_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12885-016-3012-8","volume":"17","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Chen W, Xie Z, Shao Z, Xie H, Qin G, Zhao N (2017) Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients. BMC Cancer 17(1):25. https:\/\/doi.org\/10.1186\/s12885-016-3012-8","journal-title":"BMC Cancer"},{"issue":"11","key":"3481_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891\u2013899","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3481_CR33","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3892\/or.2011.1154","volume":"25","author":"Y Yamada","year":"2011","unstructured":"Yamada Y, Nakamura K, Aoki S, Tobiume M, Zennami K, Kato Y, Nishikawa G, Yoshizawa T, Itoh Y, Nakaoka A, Yoshida E, Uchiyama T, Honda N (2011) Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer. Oncol Rep 25(4):937\u2013944. https:\/\/doi.org\/10.3892\/or.2011.1154","journal-title":"Oncol Rep"},{"issue":"5","key":"3481_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.bjc.6601205","volume":"89","author":"MI Koukourakis","year":"2003","unstructured":"Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL (2003) Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89(5):877\u2013885","journal-title":"Br J Cancer"},{"key":"3481_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002553","author":"I Puzanov","year":"2021","unstructured":"Puzanov I, Subramanian P, Yatsynovich YV, Jacobs DM, Chilbert MR, Sharma UC, Ito F, Feuerstein SG, Stefanovic F, Switzer B, Hicar MD, Curtis AB, Spangenthal EJ, Dy GK, Ernstoff MS, Vachhani P, Page BJ, Agrawal N, Khunger A, Kapoor A, Hattoum A, Schentag JJ (2021) Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002553","journal-title":"J Immunother Cancer"},{"issue":"8","key":"3481_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1634\/theoncologist.2017-0452","volume":"23","author":"M Sarocchi","year":"2018","unstructured":"Sarocchi M, Grossi F, Arboscello E, Bellodi A, Genova C, Dal Bello MG, Rijavec E, Barletta G, Rossi G, Biello F, Ghigliotti G, Canepa M, Mussap M, Brunelli C, Spallarossa P (2018) Serial troponin for early detection of nivolumab cardiotoxicity in advanced non-small cell lung cancer patients. Oncologist 23(8):936\u2013942. https:\/\/doi.org\/10.1634\/theoncologist.2017-0452","journal-title":"Oncologist"},{"issue":"24","key":"3481_CR37","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.121.058489","volume":"145","author":"J de Lavallaz","year":"2022","unstructured":"de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, L\u00f6scher WN, Schreiner B, Katan M, Jung HH, Maurer B, Hammerer-Lercher A, Mayr A, Gualandro DM, Acket A, Puelacher C, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, Glarner N, Shrestha S, Manka R, Gawinecka J, Piscuoglio S, Gallon J, Wiedemann S, Sinnreich M, Mueller C (2022) Skeletal muscle disorders: a noncardiac source of cardiac troponin T. Circulation 145(24):1764\u20131779. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058489","journal-title":"Circulation"},{"issue":"10","key":"3481_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1212\/WNL.0000000000006124","volume":"91","author":"M Touat","year":"2018","unstructured":"Touat M, Maisonobe T, Knauss S, Salem OB, Hervier B, Aur\u00e9 K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, B\u00e9hin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, L\u00e9onard-Louis S (2018) Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology 91(10):985\u2013994. https:\/\/doi.org\/10.1212\/WNL.0000000000006124","journal-title":"Neurology"},{"issue":"17","key":"3481_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","volume":"36","author":"JR Brahmer","year":"2018","unstructured":"Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA (2018) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline. J Clin Oncol 36(17):1714\u20131768. https:\/\/doi.org\/10.1200\/JCO.2017.77.6385","journal-title":"J Clin Oncol"},{"issue":"24","key":"3481_CR40","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.119.044703","volume":"141","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zlotoff DA, Awadalla M, Mahmood SS, Nohria A, Hassan MZO, Thuny F, Zubiri L, Chen CL, Sullivan RJ, Alvi RM, Rokicki A, Murphy SP, Jones-O\u2019Connor M, Heinzerling LM, Barac A, Forrestal BJ, Yang EH, Gupta D, Kirchberger MC, Shah SP, Rizvi MA, Sahni G, Mandawat A, Mahmoudi M, Ganatra S, Ederhy S, Zatarain-Nicolas E, Groarke JD, Tocchetti CG, Lyon AR, Thavendiranathan P, Cohen JV, Reynolds KL, Fradley MG, Neilan TG (2020) Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis. Circulation 141(24):2031\u20132034. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044703","journal-title":"Circulation"},{"issue":"6","key":"3481_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/onco.13740","volume":"26","author":"GE Molina","year":"2021","unstructured":"Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano-Goroff YR, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Mooradian MJ, Bardia A, Mai M, Sullivan RJ, Semenov YR, Villani AC, Reynolds KL (2021) Temporal trends and outcomes among patients admitted for immune-related adverse events: a single-center retrospective cohort study from 2011 to 2018. Oncologist 26(6):514\u2013522. https:\/\/doi.org\/10.1002\/onco.13740","journal-title":"Oncologist"},{"key":"3481_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejca.2022.07.018","volume":"177","author":"J Nowatzke","year":"2022","unstructured":"Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Zadok OI, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE (2022) Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: report from an international registry. Eur J Cancer 177:197\u2013205. https:\/\/doi.org\/10.1016\/j.ejca.2022.07.018","journal-title":"Eur J Cancer"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03481-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03481-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03481-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:32:12Z","timestamp":1710919932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03481-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3481"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03481-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocols used for this study were previously approved by the Ethics Committee\n of the First Affiliated Hospital of Zhengzhou University (approval number 2022-KY-1280-001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statements"}},{"value":"This retrospective study was approved by the hospital ethics committee, and the need for\n informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures used in this study involving human participants were in\n accordance with the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}}]}}